Grant: Planning and Dissemination Grant - Institute Community Support

Thanks to the use of antiretrovirals, most people in Canada are now living for decades with HIV. However, as people with HIV live longer the complications from hepatitis C virus (HCV), hepatitis B virus (HBV) and other co-infections have more time to develop and treatment for each disease is complicated, expensive, and has side effects. Furthermore, co-infection with HCV and HBV limits treatment options for people living with HIV. Given this background, understanding these co-infections is of critical important to those who treat HIV patients, particularly given the high frequency of co-infection, which stems from similar transmission routes. Accordingly, the purpose of the activities in this grant application is to raise awareness of the growing importance of HIV/HCV/HBV co-infection, promote and highlight the excellent co-infection research that is currently underway; develop consensus on treatment options; and support the efforts HCV/HBV knowledge brokers to partake in these activities.